110 related articles for article (PubMed ID: 38654326)
21. Comparison of plasma and CSF biomarkers in predicting cognitive decline.
Aschenbrenner AJ; Li Y; Henson RL; Volluz K; Hassenstab J; Verghese P; West T; Meyer MR; Kirmess KM; Fagan AM; Xiong C; Holtzman D; Morris JC; Bateman RJ; Schindler SE
Ann Clin Transl Neurol; 2022 Nov; 9(11):1739-1751. PubMed ID: 36183195
[TBL] [Abstract][Full Text] [Related]
22. Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease.
Wang X; Qu Y; Fan J; Ren H
Front Immunol; 2024; 15():1388734. PubMed ID: 38807603
[TBL] [Abstract][Full Text] [Related]
23. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
[TBL] [Abstract][Full Text] [Related]
24. Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice.
Carroll AS; Razvi Y; O'Donnell L; Veleva E; Heslegrave A; Zetterberg H; Vucic S; Kiernan MC; Rossor AM; Gillmore JD; Reilly MM
Amyloid; 2024 Jun; 31(2):95-104. PubMed ID: 38348665
[TBL] [Abstract][Full Text] [Related]
25. Microstructural white matter damage on MRI is associated with disease severity in Dutch-type cerebral amyloid angiopathy.
Rasing I; Vlegels N; Schipper MR; Voigt S; Koemans EA; Kaushik K; van Dort R; van Harten TW; De Luca A; van Etten ES; van Zwet EW; van Buchem MA; Middelkoop HA; Biessels GJ; Terwindt GM; van Osch MJ; van Walderveen MA; Wermer MJ
J Cereb Blood Flow Metab; 2024 Jun; ():271678X241261771. PubMed ID: 38886875
[TBL] [Abstract][Full Text] [Related]
26. Cerebral Amyloid Angiopathy in Patients with Cognitive Impairment -Cerebrospinal Fluid Biomarkers.
Rothenberg KG; Bekris L; Leverenz JB; Wu J; Lee J; Statsevych V; Ruggieri P; Jones SE
Dement Geriatr Cogn Disord; 2024 Jun; ():. PubMed ID: 38889704
[TBL] [Abstract][Full Text] [Related]
27. Quantitative electroencephalography in cerebral amyloid angiopathy.
van der Plas MC; Rasing I; Geraedts VJ; Tromp SC; Terwindt GM; van Dort R; Kaushik K; van Zwet EW; Tannemaat MR; Wermer MJH
Clin Neurophysiol; 2024 May; 164():111-118. PubMed ID: 38861875
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Evolution and Plasma Biomarkers for Excessive Daytime Sleepiness in Parkinson's Disease.
Lin J; Li C; Ou R; Hou Y; Zhang L; Wei Q; Liu K; Jiang Q; Yang T; Xiao Y; Pang D; Yu Y; Song W; Zhao B; Chen X; Yang J; Wu Y; Shang H
J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38526870
[TBL] [Abstract][Full Text] [Related]
29. Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
Panikkar D; Vivek S; Crimmins E; Faul J; Langa KM; Thyagarajan B
J Alzheimers Dis; 2023; 95(2):735-748. PubMed ID: 37574735
[TBL] [Abstract][Full Text] [Related]
30. Serum Neurofilament Light-Chain Concentrations in Essential Tremor: a Case-Control Study.
Salinas M; Salinas VH; McGurn M; Hernandez N; Louis ED
Cerebellum; 2024 Jun; 23(3):951-956. PubMed ID: 37466893
[TBL] [Abstract][Full Text] [Related]
31. Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosis.
Kang MJY; Eratne D; Wannan C; Santillo AF; Velakoulis D; Pantelis C; Cropley V
Schizophr Res; 2024 May; 267():269-272. PubMed ID: 38581830
[TBL] [Abstract][Full Text] [Related]
32. Serum NfL and GFAP as biomarkers of progressive neurodegeneration in TBI.
Shahim P; Pham DL; van der Merwe AJ; Moore B; Chou YY; Lippa SM; Kenney K; Diaz-Arrastia R; Chan L
Alzheimers Dement; 2024 May; ():. PubMed ID: 38805359
[TBL] [Abstract][Full Text] [Related]
33. Association between urinary glyphosate levels and serum neurofilament light chain in a representative sample of US adults: NHANES 2013-2014.
Yang AM; Chu PL; Wang C; Lin CY
J Expo Sci Environ Epidemiol; 2024 Mar; 34(2):287-293. PubMed ID: 37674008
[TBL] [Abstract][Full Text] [Related]
34. Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament light.
Parkin GM; Thomas EA; Corey-Bloom J
EBioMedicine; 2024 Jun; 104():105173. PubMed ID: 38815362
[TBL] [Abstract][Full Text] [Related]
35. Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays.
Fazeli B; Gómez de San José N; Jesse S; Senel M; Oeckl P; Erhart DK; Ludolph AC; Otto M; Halbgebauer S; Tumani H
Clin Chem Lab Med; 2024 Jul; 62(8):1591-1601. PubMed ID: 38353147
[TBL] [Abstract][Full Text] [Related]
36. Correlations among serum alpha-(1,6)-fucosyltransferase and early symptoms associated with Parkinson's disease: A cross-sectional retrospective study.
Wang QR; Yu X; Li Y; Zhu MZ
Brain Res Bull; 2024 Jun; 212():110959. PubMed ID: 38643887
[TBL] [Abstract][Full Text] [Related]
37. Novel inflammatory and insulin resistance indices provide a clue in cerebral amyloid angiopathy.
Zhu HH; Wang YC; He LC; Luo HY; Zong C; Yang YH; Wu JH; Song B; Gao Y; Xu YM; Li YS
Sci Rep; 2024 May; 14(1):11474. PubMed ID: 38769356
[TBL] [Abstract][Full Text] [Related]
38. Serum neurofilament light chain, inflammatory markers, and kynurenine metabolites in patients with persistent post-concussion symptoms: A cohort study.
Eggertsen PP; Palmfeldt J; Pedersen AR; Frederiksen OV; Olsen RKJ; Nielsen JF
J Neurol Sci; 2024 May; 460():123016. PubMed ID: 38636323
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark.
Määttä LL; Andersen ST; Parkner T; Hviid CVB; Bjerg L; Kural MA; Charles M; Søndergaard E; Kuhle J; Tankisi H; Witte DR; Jensen TS
Diabetes Care; 2024 Jun; 47(6):986-994. PubMed ID: 38502878
[TBL] [Abstract][Full Text] [Related]
40. Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Anderson AM; Easley KA; Kasher N; Franklin D; Heaton RK; Zetterberg H; Blennow K; Gisslen M; Letendre SL
J Neurovirol; 2018 Dec; 24(6):695-701. PubMed ID: 30105502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
